Avia Pharma has today completed the acquisition of Allergika Pharma GmbH. The company has a turnover of close to 15 million EUR and is placed in Wolfratshausen, near Munich.
Allergika is a German pharmaceutical company focused on the allergy market. It sells both dermatology products and encasing under its own brands.
The dermatology products have, in terms of market share, a very strong position in the medical cosmetics market in Germany and have experienced very high growth rates.
“By acquiring Allergika, we are taking a big step towards realizing our strategy of building a northern European pharmaceutical company. This deal gives us a great platform for further expansion in the DACH region. Allergika’s products are very well known throughout the medical community, especially among dermatologist and allergologists as well as pharmacists and the products are very appreciated by patients in Germany. We will continue to build upon Allergika’s strong market position and further develop the company” says Jacob Calmvik, CEO of Avia Pharma
For further information, please contact Jacob Calmvik, CEO Avia Pharma, jacob.calmvik@aviapharma.se, +46 703 70 71 69
